Isabelle Honoré

1.6k total citations
29 papers, 777 citations indexed

About

Isabelle Honoré is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Isabelle Honoré has authored 29 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 5 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in Isabelle Honoré's work include Cystic Fibrosis Research Advances (21 papers), Tracheal and airway disorders (9 papers) and Neonatal Respiratory Health Research (6 papers). Isabelle Honoré is often cited by papers focused on Cystic Fibrosis Research Advances (21 papers), Tracheal and airway disorders (9 papers) and Neonatal Respiratory Health Research (6 papers). Isabelle Honoré collaborates with scholars based in France, United States and Vietnam. Isabelle Honoré's co-authors include Pierre‐Régis Burgel, Reem Kanaan, D. Hubert, Daniel Dusser, Isabelle Fajac, Jeanne Chapron, Michel Monsigny, Laurence Bassinet, Étienne Audureau and Bruno Crestani and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Controlled Release and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Isabelle Honoré

27 papers receiving 761 citations

Peers

Isabelle Honoré
Verónica Marcos Germany
S. Suter Switzerland
P. Montagne France
Alison Dicker United Kingdom
Allison Handler United States
Espiridión Ramos-Martı́nez Mexico
Cedric Gunaratnam Ireland
Lydie Lemonnier France
Hans Jürgen Dornbusch Austria
Walt Klimecki United States
Verónica Marcos Germany
Isabelle Honoré
Citations per year, relative to Isabelle Honoré Isabelle Honoré (= 1×) peers Verónica Marcos

Countries citing papers authored by Isabelle Honoré

Since Specialization
Citations

This map shows the geographic impact of Isabelle Honoré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Honoré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Honoré more than expected).

Fields of papers citing papers by Isabelle Honoré

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Honoré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Honoré. The network helps show where Isabelle Honoré may publish in the future.

Co-authorship network of co-authors of Isabelle Honoré

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Honoré. A scholar is included among the top collaborators of Isabelle Honoré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Honoré. Isabelle Honoré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chassagnon, Guillaume, Jennifer Da Silva, Isabelle Honoré, et al.. (2025). Identification of structural predictors of lung function improvement in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor using deep-learning. Diagnostic and Interventional Imaging. 107(2). 62–72.
2.
Bouazza, Naïm, Frantz Foissac, Gabrielle Lui, et al.. (2025). Population Pharmacokinetics of Elexacaftor, Tezacaftor and Ivacaftor in a Real-World Cohort of Adults with Cystic Fibrosis. Clinical Pharmacokinetics. 64(6). 959–971.
3.
Chassagnon, Guillaume, Jennifer Da Silva, Reem Kanaan, et al.. (2024). Reversal of cylindrical bronchial dilatations in a subset of adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor. European Respiratory Journal. 63(3). 2301794–2301794. 10 indexed citations
4.
Sohier, Pierre, Clémence Martin, C. Lheure, et al.. (2022). Acneiform Eruption Following Elexacaftor-Tezacaftor-Ivacaftor Treatment in Patients With Cystic Fibrosis. JAMA Dermatology. 159(1). 68–68. 8 indexed citations
5.
Boissieu, Paul de, F. Benoudiba, Émilie Béquignon, et al.. (2022). Otological Manifestations in Adults with Primary Ciliary Dyskinesia: A Controlled Radio-Clinical Study. Journal of Clinical Medicine. 11(17). 5163–5163. 5 indexed citations
6.
Béquignon, Émilie, V. Escabasse, Françoise Zerah-Lancner, et al.. (2019). Follow-Up and Management of Chronic Rhinosinusitis in Adults with Primary Ciliary Dyskinesia: Review and Experience of Our Reference Centers. Journal of Clinical Medicine. 8(9). 1495–1495. 8 indexed citations
7.
Hoang-Thi, Trieu-Nghi, Marie‐Pierre Revel, Pierre‐Régis Burgel, et al.. (2018). Automated computed tomographic scoring of lung disease in adults with primary ciliary dyskinesia. BMC Pulmonary Medicine. 18(1). 194–194. 14 indexed citations
8.
Burnet, Espérie, et al.. (2018). A prospective analysis of unplanned patient-initiated contacts in an adult cystic fibrosis centre. Journal of Cystic Fibrosis. 17(5). 636–642. 1 indexed citations
9.
Hubert, D., R. Chiron, B. Camara, et al.. (2017). Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease. Journal of Cystic Fibrosis. 16(3). 388–391. 72 indexed citations
10.
Frija‐Masson, Justine, Laurence Bassinet, Isabelle Honoré, et al.. (2016). Clinical characteristics, functional respiratory decline and follow-up in adult patients with primary ciliary dyskinesia. Thorax. 72(2). 154–160. 53 indexed citations
11.
Gouya, H., Reem Kanaan, Isabelle Honoré, et al.. (2015). Renin-associated hypertension after bronchial artery embolization in cystic fibrosis. Journal of Cystic Fibrosis. 15(2). 213–215. 2 indexed citations
12.
Honoré, Isabelle & Pierre‐Régis Burgel. (2015). Primary ciliary dyskinesia in adults. Revue des Maladies Respiratoires. 33(2). 165–189. 19 indexed citations
13.
Morand, P, Clémence Martin, D. Hubert, et al.. (2015). Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. Journal of Cystic Fibrosis. 14(5). 594–599. 28 indexed citations
14.
Levesque, Éric, Emir Hoti, Daniel Azoulay, et al.. (2012). Pulmonary Complications After Elective Liver Transplantation—Incidence, Risk Factors, and Outcome. Transplantation. 94(5). 532–538. 61 indexed citations
15.
Laborde‐Castérot, Hervé, C. Donnay, Jeanne Chapron, et al.. (2011). Employment and work disability in adults with cystic fibrosis. Journal of Cystic Fibrosis. 11(2). 137–143. 30 indexed citations
16.
Monnet, I., K Atassi, Isabelle Honoré, et al.. (2011). Pleuropneumonie à Mycobacterium chelonae. Revue des Maladies Respiratoires. 28(3). 348–351. 2 indexed citations
17.
Burgel, Pierre‐Régis, Marie-Thérèse Baixench, Étienne Audureau, et al.. (2011). High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to Itraconazole. Antimicrobial Agents and Chemotherapy. 56(2). 869–874. 144 indexed citations
18.
Honoré, Isabelle, et al.. (2005). Transcription of plasmid DNA: Influence of plasmid DNA/polyethylenimine complex formation. Journal of Controlled Release. 107(3). 537–546. 70 indexed citations
19.
Honoré, Isabelle, Hilario Nunès, O Groussard, et al.. (2003). Acute Respiratory Failure after Interferon-γ Therapy of End-Stage Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 167(7). 953–957. 62 indexed citations
20.
Meynard, J.‐L., Marguerite Guiguet, L. Fonquernie, et al.. (2003). Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV‐infected patients and their epidemiologic characteristics. HIV Medicine. 4(2). 127–132. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Verónica Marcos Breakdown of academic impact, for papers by S. Suter Breakdown of academic impact, for papers by P. Montagne Breakdown of academic impact, for papers by Alison Dicker Breakdown of academic impact, for papers by Allison Handler Breakdown of academic impact, for papers by Espiridión Ramos-Martı́nez Breakdown of academic impact, for papers by Cedric Gunaratnam Breakdown of academic impact, for papers by Lydie Lemonnier Breakdown of academic impact, for papers by Hans Jürgen Dornbusch Breakdown of academic impact, for papers by Walt Klimecki
Rankless by CCL
2026